Telangana DCA Made 54 Seizures Worth Rs 19.35 Lakh In September

Hyderabad: In a major crackdown, the Telangana Drugs Control Administration (DCA) conducted 54 seizures in September, confiscating medicine stocks worth Rs 19.35 lakh.

Of these, 26 cases involved quacks engaged in unlicensed stocking and sale of drugs, while 14 relate to drugs being falsely marketed as food products or nutraceuticals. Additionally, nine raids targeted unlicensed medical shops and godowns, three focused on expired drugs, and one each involved licensed manufacturing violations and banned drugs.

Among the key raids are an operation that took place on September 4, when DCA officials seized medicines worth ₹ 4 lakh from an unlicensed godown in Sangareddy. Later, on September 18, the DCA busted an illegal sale of steroid drugs intended for gym-goers involved in bodybuilding in Hyderabad. Authorities seized steroid medicines worth ₹2 lakh, which were being sold without a valid drug licence.

The Telangana Drugs Control Administration issues drug licences to medical shops and pharmacies under the Drugs and Cosmetics Act, and selling or stocking drugs without a licence can result in imprisonment of up to five years, a release stated.

A review of the DCA’s operations from January 1 to September 30 reveals that during this period, 132 cases were booked for misleading advertisements, 92 cases targeted quacks involved in unlicensed drug sales, and 72 cases were related to price violations under the Drugs (Prices Control) Order. Other cases included 49 for unlicensed drug manufacturing, 34 for marketing drugs as food products or nutraceuticals, six for spurious drug rackets, five for unlicensed cosmetic manufacturing, three for banned drug sales, and one case involving misbranded cosmetics.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?